Orasure technologies annual report
WebJan 5, 2024 · BETHLEHEM, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,... WebMay-05-21 05:25PM. OraSure Technologies (OSUR) Beats Q1 Earnings and Revenue Estimates. Zacks. OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally.
Orasure technologies annual report
Did you know?
WebAug 9, 2024 · Orasure Technologies Inc (OSUR) 10-Q Quarterly Report Tue Aug 09 2024 Earnings Press Release 10-Q Quarterly Report 10-Q QoQ Changes Orasure Technologies Inc CIK: 1116463 Ticker: OSUR Sentiment Sections Exhibits Stats Rating Learn More Filter Sentiment: All Positive Negative Filter Category: All Financial Revenue Mgmt Change Other WebOraSure Technologies - Annual Reports/ Proxies Annual Reports/ Proxies Current 2024 Proxy Statement Please click here for Quarterly and other reports. Investors Overview Stock Information Corporate Governance Annual Reports/ Proxies Current Archive SEC/Sec. 16 …
WebMar 3, 2024 · OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability InteliSwab ® revenue of $88.9 million in Q4, up 12% sequentially; wins two new federal government contracts extending …
WebOraSure Technologies, Inc. Home WebJan 5, 2024 · BETHLEHEM, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, today announced preliminary Q4 2024 results, organizational changes, and a Board-level review of strategic alternatives to enhance …
WebMay 29, 2024 · Current estimates project approximately 550,000 patients on PrEP globally by end of 2024 with more than 2 million by the end of 2024. “UrSure was founded to develop novel diagnostics that support...
WebFind the latest OraSure Technologies, Inc. (OSUR) stock quote, history, news and other vital information to help you with your stock trading and investing. biolage fortifying leave in treatmentWebDec 31, 2024 · The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical … daily life of a physical therapistWebDec 31, 2024 · Company Overview. OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services … biolage for thin fine hairWebApr 6, 2024 · OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability Provided by GlobeNewswire Provided by GlobeNewswire... daily life of a slave in ancient romeWebMar 13, 2024 · What You Bring: B.Sc. required; M.Sc or PhD. Strongly preferred. 3+ years of direct Business Development experience selling services inAcademic, Government, and related market segments. Competitive market, industry, and working knowledge of multi-omics and workflows. Self-motivated, proactive, high-energy individual and team player … daily life of athensWebmean OraSure and its consolidated subsidiaries, unless otherwise indicated. Disclosure Regarding Forward Looking Statements This Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the "Annual Report") contains certain “forward-looking statements,” within the meaning of the Federal securities laws. daily life of a romanWebÈ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For … daily life of a teacher